Crystal Arthropathies

2

Review clinical trials related to Crystal Arthropathies. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases

Rheumatic diseases are chronic inflammatory conditions that can lead to long-term tissue damage and increased cardiovascular and metabolic risk. Advanced glycation end products (AGEs) are harmful molecules that accumulate in the body over time and are known to promote inflammation and oxidative stress. Increased AGE burden has been implicated in several chronic diseases; however, its role in rheumatic diseases has not been fully clarified. This observational, cross-sectional study aims to evaluate the accumulation of AGEs in patients with various rheumatic diseases compared with healthy individuals. AGE levels will be assessed non-invasively using skin autofluorescence measurements. By comparing AGE burden between patients and healthy controls, this study seeks to improve understanding of the potential role of AGEs in the pathophysiology of rheumatic diseases and to explore their usefulness as a non-invasive biomarker in clinical practice.

Participants needed: 300
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Bursa City HospitalUpdated: Jan 9, 2026
Eligibility criteria

Age between 18 and 75 years [+4]

Diagnosis of diabetes mellitus (type 1 or type 2) [+8]

Status: Recruiting

Novel Complex Radiodiagnostics of Peripherial Arthropathies

Chronic peripherial arthritides are common diseases with soaring public health consequences. Our goal is to assess the role of photon-counting detector computed tomography in the diagnostics of peripherial arthropathies.

Participants needed: 500
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Semmelweis UniversityUpdated: Dec 20, 2022Locations: 3
Eligibility criteria

Rheumatoid arthritis (EULAR/ACR Criteria) / Psoriatic arthritis (CASPAR Criteria... [+1]

age: <18 years, > 100 years [+2]